ScopeUniversitätsklinikum Bonn Institut für Humangenetik
163 capabilities
Accredited since July 2025
Verified Aug 2026
One of 3,107 in Germany
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Venusberg-Campus 1
Bonn 53127 , Germany
Bonn 53127 , Germany
Accreditation
Active
DAkkS
D-ML-13125-03-01
Focuses on molecular human genetics and cytogenetics testing, offering PCR-based and next-generation sequencing methods with sequence capture and Sanger sequencing capabilities on blood, DNA, oral mucosa, and saliva samples.
Accreditation Details
Accreditation Body
DAkkS
Number
D-ML-13125-03-01
Status
ActiveSince
18 July 2025
Accreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official DAkkS records.
Download Scope PDFAdditional scope documents
Test Capabilities (163)
| Standard Reference | Description | Category |
|---|---|---|
| angeborener Chromosomensatz | angeborener Chromosomensatz | Biocompatibility (ISO 10993) |
| APC | APC | Clinical Chemistry |
| Calcium (gesamt) | Calcium (gesamt) | Clinical Chemistry |
| Homocystein (gesamt) | Homocystein (gesamt) | Clinical Chemistry |
| IgE (gesamt) | IgE (gesamt) | Electrical |
| (Viruspanel) | (Viruspanel) | Food Safety Testing |
| MET | FFPE solid tumour | MET | Histopathology / Cytology |
| (Chromosomen 13, 18, 21, X, Y) | (Chromosomen 13, 18, 21, X, Y) | Molecular Diagnostics / PCR |
| (dbSNP rs3918290, rs55886062, rs67376798, rs75017182) | (dbSNP rs3918290, rs55886062, rs67376798, rs75017182) | Molecular Diagnostics / PCR |
| ABCC9, ACTA1, ACTN2, AKAP9, ANK2, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1,CASQ2, CAV3, CSRP3, DES, DSG2, DSP, DTNA, EMD, GLA, GPD1L, HCN4, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, NEXN, NKX2-5, PKP2, PLN, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SNTA1, TAZ, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTR, VCL | ABCC9, ACTA1, ACTN2, AKAP9, ANK2, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1,CASQ2, CAV3, CSRP3, DES, DSG2, DSP, DTNA, EMD, GLA, GPD1L, HCN4, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNQ1, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYL2, MYL3, NEXN, NKX2-5, PKP2, PLN, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SNTA1, TAZ, TMEM43, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTR, VCL | Molecular Diagnostics / PCR |
| ACD, BAP1, CDK4, CDKN2A, MITF, POT1, PTEN, TERT, TP53 | ACD, BAP1, CDK4, CDKN2A, MITF, POT1, PTEN, TERT, TP53 | Molecular Diagnostics / PCR |
| ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 | ACTA2, COL3A1, FBN1, MYH11, MYLK, SMAD3, TGFB2, TGFBR1, TGFBR2 | Molecular Diagnostics / PCR |
| AIP | AIP | Molecular Diagnostics / PCR |
| APC, BMPR1A, BUB1B, MSH3, MUTYH, NTHL1, POLD1, POLE, PTEN, RPS20, SMAD4, STK11, TP53, AXIN2, GREM1, RNF43 | APC, BMPR1A, BUB1B, MSH3, MUTYH, NTHL1, POLD1, POLE, PTEN, RPS20, SMAD4, STK11, TP53, AXIN2, GREM1, RNF43 | Molecular Diagnostics / PCR |
| APC, BRCA2, PALB2, PTCH1, SUFU, TP53 | APC, BRCA2, PALB2, PTCH1, SUFU, TP53 | Molecular Diagnostics / PCR |
| APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | APC, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE,PTCH1, SMARCE1, SUFU, TP53, NF1, NF2, TSC1, TSC2 | Molecular Diagnostics / PCR |
| APC, DICER1, ESR2, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, TP53 | APC, DICER1, ESR2, PRKAR1A, PTEN, RET, SDHB, SDHC, SDHD, TP53 | Molecular Diagnostics / PCR |
| ATM | ATM | Molecular Diagnostics / PCR |
| ATM, BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53 | ATM, BRCA1, BRCA2, CDKN2A, PALB2, STK11, TP53 | Molecular Diagnostics / PCR |
| AZF (Männliche Infertilität) | AZF (Männliche Infertilität) | Molecular Diagnostics / PCR |
| Aneuploidien | Aneuploidien | Molecular Diagnostics / PCR |
| BAP1, BHD/FLCN, FH, MET, PTEN, SDHB, SDHD, TP53, TSC1, TSC2, VHL, WT1 | BAP1, BHD/FLCN, FH, MET, PTEN, SDHB, SDHD, TP53, TSC1, TSC2, VHL, WT1 | Molecular Diagnostics / PCR |
| BAP1, CHEK2, EGFR, TP53 | BAP1, CHEK2, EGFR, TP53 | Molecular Diagnostics / PCR |
| BHD/FLCN | BHD/FLCN | Molecular Diagnostics / PCR |
| BRCA1 (HBOC) | BRCA1 (HBOC) | Molecular Diagnostics / PCR |
| BRCA1, BRCA2, ATM, CHEK2, PALB2, RAD51C, RAD51D, BRIP1, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE, RAD51D, STK11, TP53 | BRCA1, BRCA2, ATM, CHEK2, PALB2, RAD51C, RAD51D, BRIP1, EPCAM, MLH1, MSH2, MSH6, PMS2, POLD1, POLE, RAD51D, STK11, TP53 | Molecular Diagnostics / PCR |
| BRCA2, CHEK2 (HBOC) | BRCA2, CHEK2 (HBOC) | Molecular Diagnostics / PCR |
| Bannayan-Ruvalcaba-Riley-Syndrom | Bannayan-Ruvalcaba-Riley-Syndrom | Molecular Diagnostics / PCR |
| Birt-Hogg-Dubé-Syndrom | Birt-Hogg-Dubé-Syndrom | Molecular Diagnostics / PCR |
| Brustkrebs bei V. a. anderes | Brustkrebs bei V. a. anderes | Molecular Diagnostics / PCR |
| CBAVD (Illumina TruSight EBM Panel): CFTR | CBAVD (Illumina TruSight EBM Panel): CFTR | Molecular Diagnostics / PCR |
| CDH1 | CDH1 | Molecular Diagnostics / PCR |
| CDH1, CTNNA1, EPCAM, MLH1, MSH2, MSH6, PMS2, SMAD4, STK11, TP53 | CDH1, CTNNA1, EPCAM, MLH1, MSH2, MSH6, PMS2, SMAD4, STK11, TP53 | Molecular Diagnostics / PCR |
| CDKN1B, MEN1 | CDKN1B, MEN1 | Molecular Diagnostics / PCR |
| CDKN2A, CDK4 | CDKN2A, CDK4 | Molecular Diagnostics / PCR |
| CFTR (Mukoviszidose, CBAVD) | CFTR (Mukoviszidose, CBAVD) | Molecular Diagnostics / PCR |
| COL3A1 (Ehlers-Danlos-Syndrom) | COL3A1 (Ehlers-Danlos-Syndrom) | Molecular Diagnostics / PCR |
| CYLD | CYLD | Molecular Diagnostics / PCR |
| DRPLA/ATN1, SCA1,2,3,6,7, SCA17/TBP, FRDA, FXN, FMR1 | DRPLA/ATN1, SCA1,2,3,6,7, SCA17/TBP, FRDA, FXN, FMR1 | Molecular Diagnostics / PCR |
| Demenz | Demenz | Molecular Diagnostics / PCR |
| Dihydropyrimidin-Dehydrogenase | Dihydropyrimidin-Dehydrogenase | Molecular Diagnostics / PCR |
| EPCAM, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, TP53 | EPCAM, MLH1, MSH2, MSH6, MUTYH, NTHL1, PMS2, POLD1, POLE, PTEN, TP53 | Molecular Diagnostics / PCR |
| EXT1, EXT2 | EXT1, EXT2 | Molecular Diagnostics / PCR |
| EXT1, EXT2 (Multiple Exostosis) | EXT1, EXT2 (Multiple Exostosis) | Molecular Diagnostics / PCR |
| Eiigkeitsbestimmung | Eiigkeitsbestimmung | Molecular Diagnostics / PCR |
| Erblicher Darmkrebs | Erblicher Darmkrebs | Molecular Diagnostics / PCR |
| Erweiterung des Illumina TruSight | Erweiterung des Illumina TruSight | Molecular Diagnostics / PCR |
| FBN1 (Marfan-Syndrom) | FBN1 (Marfan-Syndrom) | Molecular Diagnostics / PCR |
| FH (Hereditärer Nierenkrebs) | FH (Hereditärer Nierenkrebs) | Molecular Diagnostics / PCR |
| GJB1, MPZ, PMP22 (CMT1/HMSN) | GJB1, MPZ, PMP22 (CMT1/HMSN) | Molecular Diagnostics / PCR |
| GRHL3 | GRHL3 | Molecular Diagnostics / PCR |
| HNF1A (TCF1) | HNF1A (TCF1) | Molecular Diagnostics / PCR |
| HNPCC/Lynch-Syndrom | HNPCC/Lynch-Syndrom | Molecular Diagnostics / PCR |
| HOXB13 (Mut. G84E) | HOXB13 (Mut. G84E) | Molecular Diagnostics / PCR |
| Hereditäre Frontotemporale | Hereditäre Frontotemporale | Molecular Diagnostics / PCR |
| Hereditäre Gastrointestinale | Hereditäre Gastrointestinale | Molecular Diagnostics / PCR |
| Hereditäre Multiple Endokrine | Hereditäre Multiple Endokrine | Molecular Diagnostics / PCR |
| Hereditäre Neurofibromatose Typ | Hereditäre Neurofibromatose Typ | Molecular Diagnostics / PCR |
| Hereditäre Schwannomatose | Hereditäre Schwannomatose | Molecular Diagnostics / PCR |
| Hereditäre Tuberöse Sklerose Typ | Hereditäre Tuberöse Sklerose Typ | Molecular Diagnostics / PCR |
| Hereditäre Zylindromatosis | Hereditäre Zylindromatosis | Molecular Diagnostics / PCR |
| Hereditärer Hirntumor | Hereditärer Hirntumor | Molecular Diagnostics / PCR |
| Hereditärer Magenkrebs | Hereditärer Magenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Nierenkrebs | Hereditärer Nierenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Schilddrüsenkrebs | Hereditärer Schilddrüsenkrebs | Molecular Diagnostics / PCR |
| Hereditärer Wilms-Tumor | Hereditärer Wilms-Tumor | Molecular Diagnostics / PCR |
| Hereditäres Angioödem Typ I-III | Hereditäres Angioödem Typ I-III | Molecular Diagnostics / PCR |
| Hereditäres Endometriumkarzinom | Hereditäres Endometriumkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Hepatisches Adenom | Hereditäres Hepatisches Adenom | Molecular Diagnostics / PCR |
| Hereditäres Lungenkarzinom | Hereditäres Lungenkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Medulloblastom | Hereditäres Medulloblastom | Molecular Diagnostics / PCR |
| Hereditäres Melanom | Hereditäres Melanom | Molecular Diagnostics / PCR |
| Hereditäres Ovarialkarzinom | Hereditäres Ovarialkarzinom | Molecular Diagnostics / PCR |
| Hereditäres Pankreaskarzinom | Hereditäres Pankreaskarzinom | Molecular Diagnostics / PCR |
| Hereditäres Phäochromozytom | Hereditäres Phäochromozytom | Molecular Diagnostics / PCR |
| Hereditäres Pleuropulmonales | Hereditäres Pleuropulmonales | Molecular Diagnostics / PCR |
| Hereditäres Prostatakarzinom | Hereditäres Prostatakarzinom | Molecular Diagnostics / PCR |
| Herzerkrankungen, gesamt | Herzerkrankungen, gesamt | Molecular Diagnostics / PCR |
| IRF6 | IRF6 | Molecular Diagnostics / PCR |
| LZTR1, NF2, SMARCB1 | LZTR1, NF2, SMARCB1 | Molecular Diagnostics / PCR |
| Li-Fraumeni-Syndrom | Li-Fraumeni-Syndrom | Molecular Diagnostics / PCR |
| MECP2 (Rett-Syndrom) | MECP2 (Rett-Syndrom) | Molecular Diagnostics / PCR |
| MECP2-Gen, RETT Syndrom | MECP2-Gen, RETT Syndrom | Molecular Diagnostics / PCR |
| MLH1, MSH2 (HNPCC, CMMRD) | MLH1, MSH2 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| MLH1, MSH2, MSH6, PMS2, EPCAM | MLH1, MSH2, MSH6, PMS2, EPCAM | Molecular Diagnostics / PCR |
| MSH6 (HNPCC, CMMRD) | MSH6 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| MeCP2; Rett-Syndrom | MeCP2; Rett-Syndrom | Molecular Diagnostics / PCR |
| NF1 | NF1 | Molecular Diagnostics / PCR |
| NF1, SPRED1 | NF1, SPRED1 | Molecular Diagnostics / PCR |
| NF2 | NF2 | Molecular Diagnostics / PCR |
| NSD1, NFIX (Sotos-Syndrom) | NSD1, NFIX (Sotos-Syndrom) | Molecular Diagnostics / PCR |
| Neoplasie, Typ 1/4 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): MEN1, CDKN1B, CDC73 (HRPT2) | Neoplasie, Typ 1/4 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): MEN1, CDKN1B, CDC73 (HRPT2) | Molecular Diagnostics / PCR |
| Neoplasie, Typ 2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): RET | Neoplasie, Typ 2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): RET | Molecular Diagnostics / PCR |
| OMIM*176872, MET | OMIM*176872, MET | Molecular Diagnostics / PCR |
| PDGFRA, SDHA, SDHB, SDHC, SDHD | PDGFRA, SDHA, SDHB, SDHC, SDHD | Molecular Diagnostics / PCR |
| PMS2 (HNPCC, CMMRD) | PMS2 (HNPCC, CMMRD) | Molecular Diagnostics / PCR |
| PSEN1, PSEN2 | PSEN1, PSEN2 | Molecular Diagnostics / PCR |
| PTCH1 (Gorlin-Syndrom) | PTCH1 (Gorlin-Syndrom) | Molecular Diagnostics / PCR |
| PTEN, AKT1, PIK3CA, SEC23B | PTEN, AKT1, PIK3CA, SEC23B | Molecular Diagnostics / PCR |
| RET (MEN2) | RET (MEN2) | Molecular Diagnostics / PCR |
| RHBDF2 | RHBDF2 | Molecular Diagnostics / PCR |
| Repeatanlyse FMR1 | Repeatanlyse FMR1 | Molecular Diagnostics / PCR |
| Rhabdoid-Prädispositions-Syndrom | Rhabdoid-Prädispositions-Syndrom | Molecular Diagnostics / PCR |
| SDHAF2 | SDHAF2 | Molecular Diagnostics / PCR |
| SHOX (Kleinwuchssyndrom) | SHOX (Kleinwuchssyndrom) | Molecular Diagnostics / PCR |
| SMARCB1, SMARCA4 | SMARCB1, SMARCA4 | Molecular Diagnostics / PCR |
| SPRED1 (Hereditäre NF1) | SPRED1 (Hereditäre NF1) | Molecular Diagnostics / PCR |
| STK11, PRKAR1A | STK11, PRKAR1A | Molecular Diagnostics / PCR |
| STK11; V. a. Peutz-Jeghers-Syndrom | STK11; V. a. Peutz-Jeghers-Syndrom | Molecular Diagnostics / PCR |
| SUFU | SUFU | Molecular Diagnostics / PCR |
| Stromatumore (GIST) | Stromatumore (GIST) | Molecular Diagnostics / PCR |
| Syndrom (Fowler-Syndrom) | Syndrom (Fowler-Syndrom) | Molecular Diagnostics / PCR |
| Syndrom-Screening, MR-X | Syndrom-Screening, MR-X | Molecular Diagnostics / PCR |
| TBX1 (DiGeorge Syndrom) | TBX1 (DiGeorge Syndrom) | Molecular Diagnostics / PCR |
| TGFBR1, TGFBR2 (Marfan-Syndrom) | TGFBR1, TGFBR2 (Marfan-Syndrom) | Molecular Diagnostics / PCR |
| TP53 (Li-Fraumeni-Syndrom) | TP53 (Li-Fraumeni-Syndrom) | Molecular Diagnostics / PCR |
| TP53, CHEK2, POT1 | TP53, CHEK2, POT1 | Molecular Diagnostics / PCR |
| TSC1 (Tuberöse Sklerose Typ 1) | TSC1 (Tuberöse Sklerose Typ 1) | Molecular Diagnostics / PCR |
| TSC2 (Tuberöse Sklerose Typ 2) | TSC2 (Tuberöse Sklerose Typ 2) | Molecular Diagnostics / PCR |
| Testung (DPD)/5-FU-Toxizität: DPYD | Testung (DPD)/5-FU-Toxizität: DPYD | Molecular Diagnostics / PCR |
| Thorakale Aortenerweiterung | Thorakale Aortenerweiterung | Molecular Diagnostics / PCR |
| VHL | VHL | Molecular Diagnostics / PCR |
| VHL (Von-Hippel-Lindau-Syndrom) | VHL (Von-Hippel-Lindau-Syndrom) | Molecular Diagnostics / PCR |
| VHL, FH, FLCN, MET, WT1 | VHL, FH, FLCN, MET, WT1 | Molecular Diagnostics / PCR |
| Van der Woude-Syndrom | Van der Woude-Syndrom | Molecular Diagnostics / PCR |
| WT1 (Wilms-Tumor) | WT1 (Wilms-Tumor) | Molecular Diagnostics / PCR |
| XII (Hagemann-Faktor) F12, PLG, ANGPT1 | XII (Hagemann-Faktor) F12, PLG, ANGPT1 | Molecular Diagnostics / PCR |
| Ösophaguskarzinom | Ösophaguskarzinom | Molecular Diagnostics / PCR |
| (Illumina TruSight Cardio Panel): | (Illumina TruSight Cardio Panel): | Other |
| (institutseigene Erweiterung des | (institutseigene Erweiterung des | Other |
| 1/2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): | 1/2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): | Other |
| APP, PSEN1, PSEN2 (Hereditäre | APP, PSEN1, PSEN2 (Hereditäre | Other |
| Alzheimer Demenz) | Alzheimer Demenz) | Other |
| Angioödem) | Angioödem) | Other |
| BMPR1, SMAD4, PTEN (Juvenile | BMPR1, SMAD4, PTEN (Juvenile | Other |
| CLOVES-Syndrom (institutseigene | CLOVES-Syndrom (institutseigene | Other |
| Carney-Komplex (institutseigene | Carney-Komplex (institutseigene | Other |
| Carney-Komplex) | Carney-Komplex) | Other |
| Cowden-Syndrom (institutseigene | Cowden-Syndrom (institutseigene | Other |
| DMD (Muskeldystrophie Typ | DMD (Muskeldystrophie Typ | Other |
| Dermatologische Erkrankungen, gesamt: ADAM10, APCDD1, CDH3, | Dermatologische Erkrankungen, gesamt: ADAM10, APCDD1, CDH3, | Other |
| Duchenne/Becker) | Duchenne/Becker) | Other |
| ELN, LIMK1 (Williams Beuren | ELN, LIMK1 (Williams Beuren | Other |
| Ehlers-Danlos-Syndrom (Illumina | Ehlers-Danlos-Syndrom (Illumina | Other |
| Fragiles-X-Syndrom, POF, FXTAS: | Fragiles-X-Syndrom, POF, FXTAS: | Other |
| Frontotemporale Demenz) | Frontotemporale Demenz) | Other |
| Hereditäre Alzheimer Demenz: | Hereditäre Alzheimer Demenz: | Other |
| Hereditäre Leiomyomatose und | Hereditäre Leiomyomatose und | Other |
| Hereditäre Tylosis (Keratosis | Hereditäre Tylosis (Keratosis | Other |
| Hereditärer Brust- und | Hereditärer Brust- und | Other |
| Kontaminationsausschluss/ | Kontaminationsausschluss/ | Other |
| MAPT, GRN (Hereditäre | MAPT, GRN (Hereditäre | Other |
| Marfan-Syndrom (Illumina TruSight | Marfan-Syndrom (Illumina TruSight | Other |
| Morbus Osler (institutseigene | Morbus Osler (institutseigene | Other |
| Polyposis) | Polyposis) | Other |
| Popliteales Pterygium-Syndrom: | Popliteales Pterygium-Syndrom: | Other |
| Proteus-Syndrom (institutseigene | Proteus-Syndrom (institutseigene | Other |
| SERPING1, F12 (Hereditäres | SERPING1, F12 (Hereditäres | Other |
| SMARCB1 (Hereditäre | SMARCB1 (Hereditäre | Other |
| Schwannomatose) | Schwannomatose) | Other |
| Typ1+2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): | Typ1+2 (institutseigene Erweiterung des Illumina TruSight Cancer Panel): | Other |
| WT1 | FFPE slides (Formalin fixed | Wilms Tumour WT1 | Other |
| palmoplantaris) mit | palmoplantaris) mit | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.